文献速递神经肿瘤小儿神经外科与脑积水

儿童散发性视路胶质瘤治疗后的视觉结局:系统综述

Visual Outcomes After Treatment for Sporadic Optic Pathway Gliomas in Pediatric Patients: A Systematic Review.
PubMed 文献 · World Neurosurg · 2022-04-14

该系统综述纳入31篇文献,评估儿童散发性视路胶质瘤经观察、化疗、放疗或手术后的视觉结局。45.2%(14/31)的研究报告视觉恶化,35.5%(11/31)无变化,19.4%(6/31)改善。化疗可能获得最有利的视觉结局,但无法从系统综述确定因果关系。

要点

  • 45.2%(14/31)研究报告治疗后视觉恶化,19.4%(6/31)报告改善。
  • 化疗研究中改善和恶化各占35.7%(5/14),无变化占28.6%(4/14)。
  • 手术研究中62.5%(5/8)报告视觉恶化,37.5%(3/8)无变化。

核心结论

  • 大多数研究显示儿童散发性视路胶质瘤经观察、化疗、放疗或手术后视觉稳定至较差。
  • 化疗可能与最有利的视觉结局相关。
  • 无法从系统综述确定因果关系。

研究设计与样本

  • 系统综述,检索PubMed、Embase、Scopus、Cochrane和CINAHL Plus数据库,最终纳入31篇文章。

主要发现

  • 45.2%(14/31)的研究报告治疗后视觉恶化,35.5%(11/31)无变化,19.4%(6/31)改善。
  • 放疗研究中50.0%(4/8)无变化,37.5%(3/8)恶化,12.5%(1/8)改善。
  • 化疗研究中改善和恶化各占35.7%(5/14),无变化占28.6%(4/14)。
  • 手术研究中62.5%(5/8)报告恶化,37.5%(3/8)无变化。
  • 唯一一项观察性研究报告视觉恶化。

关键数值与推荐

  • 与视觉结局不良相关的因素包括就诊时视力下降的体征和症状、眶内视神经受累、需手术的颅内高压。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 治疗指征未知且缺乏完整临床细节。
  • 无法从系统综述确定因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Optic pathway gliomas (OPGs) typically occur in the first decade of life and 40%-50% are not associated with neurofibromatosis 1 (NF1) (sporadic). Management strategies are often patient specific because of the variable and unpredictable course. No study has summarized the effect of treatment strategies on visual outcomes in the subset of pediatric patients with sporadic OPG. METHODS: We conducted a systematic review to determine the nature of visual outcomes in pediatric patients with sporadic, non-NF1-associated OPG using the PubMed, Embase, Scopus, Cochrane, and CINAHL Plus databases. Visual outcomes were categorized as improved, unchanged, or deteriorated. RESULTS: Of 1316 results, 31 articles were included. Treatment indications are unknown with full clinical detail. A total of 45.2% (14/31) reported deteriorated outcomes after treatment, 35.5% (11/31) no change, and 19.4% (6/31) improvement. Of radiotherapy studies, 50.0% (4/8) found no change, 37.5% (3/8) deterioration, and 12.5% (1/8) improvement. Of chemotherapy studies, 35.7% (5/14) each showed improvement and deterioration, whereas 28.6% (4/14) showed no change. Of surgical studies, 62.5% (5/8) indicated deterioration, and 37/5% (3/8) indicated no change. The singular study examining observation reported deterioration in visual outcomes. Factors associated with poor visual outcomes included signs and symptoms of visual decline at presentation, involvement of the intraorbital optic nerve, and intracranial hypertension requiring surgery. Causality cannot be determined from systematic review. CONCLUSIONS: Most studies showed that vision in pediatric patients with sporadic OPG is stable to poor after observation, chemotherapy, radiotherapy, or surgery. Chemotherapy may be associated with most favorable visual outcomes.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Shlobin NA, Montgomery EY, Mohammad LM, et al. Visual Outcomes After Treatment for Sporadic Optic Pathway Gliomas in Pediatric Patients: A Systematic Review. World Neurosurg. 2022. PMID: 35430402. doi:10.1016/j.wneu.2022.04.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。